Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Bangkok Post - August 26, 2005
Supoj Wancharoen
They raised questions about its safety and the willingness of the volunteers and demanded a halt to the trial.
The three-year trial, which began in June, is sponsored by the Bangkok Metropolitan Administration and the US Centers for Disease Control and Prevention, with pharmaceutical support from drug company Gilead Sciences.
Aiming to recruit 1,600 intravenous drug users treated at 17 rehabilitation centres in Bangkok, the trial has so far been joined by more than 100 volunteers.
The protesters asked to meet Deputy Bangkok Governor Pensri Pichaisanit and deputy city clerk Pitinan Natrujiroj, who are in charge of the project.
Dr Pensri promised to consult the project's researchers and let the protesters know the outcome in one week.
050826
BP050807
Copyright © 2005 - The Bangkok Post. Reproduction of this article (other than one copy for personal reference) must be cleared through the Bangkok Post.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .